CN102772525B

CN102772525B - Traditional Chinese medicine for wind-heat type acute bronchitis

Info

Publication number: CN102772525B
Application number: CN201210221568.7A
Authority: CN
Inventors: 孟磊
Original assignee: Individual
Current assignee: Individual
Priority date: 2012-06-30
Filing date: 2012-06-30
Publication date: 2014-02-26
Anticipated expiration: 2032-06-30
Also published as: CN102772525A

Abstract

The invention discloses a traditional Chinese medicine for wind-heat type acute bronchitis. The traditional Chinese medicine is composed of raw materials of, by weight, 1-5g of cicada slough, 1-5g of radix glycyrrhizae preparata, 13-17g of cynanchum glaucescens, 4-8g of atractylodes macrocephala koidz, 8-12g of saposhnicovia divaricata, 4-8g of rhizoma cimicifugae, 4-8g of pericarpium citri reticulatae, 4-8g of japaneses ardisia herb, 8-12g of heterophylly falsestarwort root, 8-12g of globe amaranth flowers, 13-17g of radix bupleuri, 8-12g of honey-fried flos farfarae, 13-17g of semen sojae praeparatum, 8-12g of endothelium corneum gigeriae galli and 1-5g of cockleburs. According to the traditional Chinese medicine for the wind-heat type acute bronchitis, compatibility of medicines of the formula is reasonable, the defects that prior medicines for treating the acute bronchitis are poor in efficacy and excessive in side effect are overcome, pertinence is high, a large dose of traditional Chinese medicines which are beneficial to lungs and capable of clearing heat are used, and the traditional Chinese medicine has an excellent effect on the wind-heat type acute bronchitis.

Description

Chinese medicine for anemopyretic acute bronchitis

Technical field:

The present invention relates generally to the field of Chinese medicines, relates in particular to a kind of Chinese medicine for anemopyretic acute bronchitis.

Background technology:

Acute bronchitis is the bronchial mucosa inflammation due to the pathogenic infections such as virus or antibacterial.Being the infant commonly encountered diseases in period, frequently-occurring disease, after being often secondary to upper respiratory tract infection, is often also the Early manifestation of pneumonia.How primary disease involves trachea, bronchus simultaneously, therefore proper naming should be acute tracheobronchitis.

At present, western medicine acute bronchitis exists early and uses, the phenomenon of abuse of antibiotics, causes drug resistance to increase year by year.And abuse cough medicine is very serious, is not only unprofitable to the improvement of the state of an illness, also likely increases the weight of the state of an illness.Treatment by Chinese herbs acute bronchitis, such as: JIZHI TANGJIANG, exist compatibility of drugs not too reasonable, there is the defect of weak curative effect.

Summary of the invention:

The object of the invention is exactly in order to make up the defect of prior art, and a kind of Chinese medicine for anemopyretic acute bronchitis is provided, and its good effect, has no side effect.

The present invention is achieved by the following technical solutions:

Chinese medicine for anemopyretic acute bronchitis, is characterized in that: the weight proportion of its each raw material components is: Periostracum Cicadae 1-5, Radix Glycyrrhizae Preparata 1-5, Rhizoma Cynanchi Stauntonii 13-17, Rhizoma Atractylodis Macrocephalae 4-8, Radix Saposhnikoviae 8-12, Rhizoma Cimicifugae 4-8, Pericarpium Citri Reticulatae 4-8, Herba Ardisiae Japonicae 4-8, Radix Pseudostellariae 8-12, Flos Gomphrenae 8-12, Radix Bupleuri 13-17, honey-fried FLOS FARFARAE 8-12, Semen Sojae Preparatum 13-17, Endothelium Corneum Gigeriae Galli 8-12, phytolacca acinosa roxb.var. 1-5.

Chinese medicine for anemopyretic acute bronchitis, is characterized in that: the weight proportion of its each raw material components is: Periostracum Cicadae 3, Radix Glycyrrhizae Preparata 3, Rhizoma Cynanchi Stauntonii 15, the Rhizoma Atractylodis Macrocephalae 6, Radix Saposhnikoviae 10, Rhizoma Cimicifugae 6, Pericarpium Citri Reticulatae 6, Herba Ardisiae Japonicae 6, Radix Pseudostellariae 10, Flos Gomphrenae 10, Radix Bupleuri 15, honey-fried FLOS FARFARAE 10, Semen Sojae Preparatum 15, Endothelium Corneum Gigeriae Galli 10, phytolacca acinosa roxb.var. 3.

Advantage of the present invention is:

Formula compatibility of the present invention is reasonable, has solved the defect that existing treatment acute bronchitis medicine effect is low, side effect is large, with strong points, reuses lung benefiting heat-clearing type Chinese medicine, for anemopyretic acute bronchitis, has good curative effect.

The specific embodiment:

For the Chinese medicine of anemopyretic acute bronchitis, the weight of its each raw material components (g) is: Periostracum Cicadae 3, Radix Glycyrrhizae Preparata 3, Rhizoma Cynanchi Stauntonii 15, the Rhizoma Atractylodis Macrocephalae 6, Radix Saposhnikoviae 10, Rhizoma Cimicifugae 6, Pericarpium Citri Reticulatae 6, Herba Ardisiae Japonicae 6, Radix Pseudostellariae 10, Flos Gomphrenae 10, Radix Bupleuri 15, honey-fried FLOS FARFARAE 10, Semen Sojae Preparatum 15, Endothelium Corneum Gigeriae Galli 10, phytolacca acinosa roxb.var. 3.

Take above each raw material components, according to the routine fashion of decoction, add water and boil decoction and take, every day potion, potion is taken at twice.

For the therapeutic effect of check decoction of the present invention, spy carries out following experimental technique, and test method adopts random packet, control experiment method.

Choose 80 routine anemopyretic acute bronchitis patients, these patients show as cough, cough up phlegm not well, and expectorant yellow skin is thick, xerostomia pharyngalgia, nose stream yellow thick nasal discharge or the heat that occurs together, sweating, headache, aversion to wind, yellow and thin fur, floating and rapid pulse.

Adopt random digit table method to be divided at random two groups this 80 routine patient.Male's 26 examples in matched group 40 examples, women's 14 examples, age 1-15 year, 5 years old mean age.In treatment group 40 examples, male's 22 examples, women's 18 examples, age 2-11 year, 4 years old mean age.

The < < traditional Chinese medical science disease Standardization of diagnosis and curative effect > > judgement curative effect of promulgating according to State Administration of Traditional Chinese Medicine, diagnostic criteria is:

Effective: the transference cure or obviously alleviate of coughing, spit, auscultation of lung and Chest X-rays are normal or be clearly better, and pulmonary abnormalities changes integrated value and declines >=70%, and abnormal physical and chemical index approaches normal.

Effective: cough and expectoration alleviates, other symptoms obviously alleviate, integrated value decline 30%-69%, and abnormal physical and chemical index makes moderate progress.

Invalid: cough and other symptoms are without obvious change, integrated value decline <30%, abnormal physical and chemical index is not improved.

For matched group: adopt common Therapeutic Method: take Lingyang lung clearing ball or anemopyretic cold electuary.For treatment group: give treatment by Chinese herbs of the present invention.

Observe 7 days, therapeutic outcome is as follows:

?	Effective	Effectively	Invalid
				Treatment group number	30	10	0
Contrast groups number	9	19	12

By above contrast, can find out, the curative effect of Chinese medicine of the present invention is good.

Claims

1. for the Chinese medicine of anemopyretic acute bronchitis, it is characterized in that: the weight proportion of its each raw material components is: Periostracum Cicadae 1-5, Radix Glycyrrhizae Preparata 1-5, Rhizoma Cynanchi Stauntonii 13-17, Rhizoma Atractylodis Macrocephalae 4-8, Radix Saposhnikoviae 8-12, Rhizoma Cimicifugae 4-8, Pericarpium Citri Reticulatae 4-8, Herba Ardisiae Japonicae 4-8, Radix Pseudostellariae 8-12, Flos Gomphrenae 8-12, Radix Bupleuri 13-17, honey-fried FLOS FARFARAE 8-12, Semen Sojae Preparatum 13-17, Endothelium Corneum Gigeriae Galli 8-12, phytolacca acinosa roxb.var. 1-5.

2. the Chinese medicine for anemopyretic acute bronchitis according to claim 1, is characterized in that: the weight proportion of its each raw material components is: Periostracum Cicadae 3, Radix Glycyrrhizae Preparata 3, Rhizoma Cynanchi Stauntonii 15, the Rhizoma Atractylodis Macrocephalae 6, Radix Saposhnikoviae 10, Rhizoma Cimicifugae 6, Pericarpium Citri Reticulatae 6, Herba Ardisiae Japonicae 6, Radix Pseudostellariae 10, Flos Gomphrenae 10, Radix Bupleuri 15, honey-fried FLOS FARFARAE 10, Semen Sojae Preparatum 15, Endothelium Corneum Gigeriae Galli 10, phytolacca acinosa roxb.var. 3.